Biotech's New Frontier
Reshma discusses the transformative potential of biotechnology, especially in light of the pandemic. She emphasizes Ginkgo's mission to simplify biological engineering and its crucial role in mRNA vaccine production. With a $15 billion valuation on the horizon, Reshma highlights the need for responsible innovation in biotech, balancing ambition with care for the community and environment.In this clip
From this podcast

Masters of Scale
Rapid Response: The promise and peril of engineering biology, w/Ginkgo Bioworks Reshma Shetty
Related Questions
Are there concerns about mRNA vaccine safety in the episode Rapid Response: The promise and peril of engineering biology, w/Ginkgo Bioworks Reshma Shetty and the clip Engineering Biology's Future?
Are there concerns about mRNA vaccine safety in the episode Rapid Response: The promise and peril of engineering biology, w/Ginkgo Bioworks Reshma Shetty and the clip mRNA Vaccine Innovation?
Are there concerns about mRNA vaccine safety in the episode Rapid Response: The promise and peril of engineering biology, w/Ginkgo Bioworks Reshma Shetty and the clip mRNA Vaccine Manufacturing?